| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70983fc568d51b95846345a31cbd9b99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5565240f17e3704473a40ce899dec3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ae0580f32eca158ede41cb4a2246180
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8302d54d73eddb844bf297a32a378b46 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 |
| filingDate |
2012-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25e80bcb327b9cc88b08490a66b0a304
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9a08d05dbbe5ae1a2e08c46c4ecbe2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1942f42aacbe59e7ee10668314fd0380 |
| publicationDate |
2012-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012111961-A3 |
| titleOfInvention |
Orally administrated sustained-release tablet containing tianeptine or pharmaceutically acceptable salt thereof |
| abstract |
The present invention relates to an orally administrated sustained-release tablet containing tianeptine or a pharmaceutically acceptable salt thereof, and more particularly, to a sustained-release pill for taking tianeptine sodium once a day. |
| priorityDate |
2011-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |